4.7 Article

Post radiation hysterectomy in locally advanced cervical cancer: Outcomes and dosimetric impact

Journal

RADIOTHERAPY AND ONCOLOGY
Volume 120, Issue 3, Pages 460-466

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.radonc.2016.07.010

Keywords

Cervix cancer; Chemoradiation; Image-guided adaptive brachytherapy; Hysterectomy; Late morbidity

Ask authors/readers for more resources

Purposes: Firstly, to evaluate the impact of completion hysterectomy after chemoradiation and image-guided adaptive brachytherapy (IGABT) in locally advanced cervical cancer. Secondly, to assess a potential differential dose-effect relationship for the rectum and bladder according to the realization of hysterectomy. Material and methods: Two cohorts of patients were identified, differing by the realization of completion hysterectomy. Inclusions were limited to FIGO stage I-II, with no para-aortic involvement. All patients received a combination of pelvic chemoradiation followed by IGABT. Their outcomes and morbidity were reviewed. Log-rank tests were used to compare survivals. Probit analyses were performed to study dose-volume effect relationships. Results: The two cohorts comprised 54 patients in the completion surgery group and 157 patients in the definitive radiotherapy group. They were well balanced, except for the mean follow-up, significantly longer in the post hysterectomy cohort and the use of PET-CT in the work-up, more frequent in the definitive radiotherapy cohort. Although less local relapses were reported in the hysterectomy group, the 5 year disease-free and overall survival did not differ between groups. The cumulative incidence of severe late morbidity was significantly increased in the hysterectomy cohort: 22.5% versus 6.5% at 5 years (p = 0.016). Dose-volume effects were observed for the bladder, with the D-2cm3 corresponding with a 10% probability of late severe morbidity urinary events (ED10) of 67.8 Gy and 91.9 Gy in the hysterectomy and definitive radiotherapy cohorts, respectively. A D-90 CTVHR of 85 Gy (planning aim) corresponded with a 93.3% rate of local control in the definitive radiotherapy cohort whereas it corresponded with a 77.3% chance to have a good histologic response (complete response or microscopic residual disease) in the hysterectomy group. Conclusion: No benefit from completion hysterectomy in terms of overall or disease-free survival rates was observed, which was moreover responsible for an increase of the severe late morbidity. The realization of post-radiation hysterectomy resulted in a shift of the ED10 of 24.1 Gy. (C) 2016 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available